The 3rd Annual Echo in Pediatric and Congenital Heart Disease is a two-day virtual course, presenting the latest information on established and emerging cardiovascular ultrasound technologies, clinical care and practical considerationsin children and adults with congenital heart disease. Expert physician and sonographer faculty discuss current technologies with a particular focus on how they can be effectively applied in the clinical setting.
Topics include:
- What’s New In The Guidelines?
- PCHD From Around the World
- Investigating Echo in CHD
- Is Echo Enough? Multi-Modality Imaging – Debate & Talk
- Fetal Cardiology Cases: Torture the Experts!
- Imaging ACHD from the Sonographer’s Perspective
- 3D For Everything
- Career Development Roundtable: How Organizations Can Enhance My Echo Career
All sessions will have dedicated Question and Answer time where faculty will be joining live to answer participantquestions.
Learning Objectives
At the end of this course, that participant will be able to:
- Describe imaging goals and approaches to a variety of challenging forms of congenital heart disease, from infancy to adulthood.
- Understand and apply current techniques in imaging assessment of cardiac anatomy and function, including contrast imaging in pediatrics, advanced 3D echo, myocardial work and CRT in children.
- Apply techniques to promote well-being, resiliency, and career advancement of your entire sonographer team.
jopatclo wrote: Great comment from Miro Cernetig on Linkedin from Hugh's repost (A.I. is going to vastly improve health care for everyone. One application, now in use, is Ventripoint. It turns ultrasounds of the heart into detailed images that are created in a fraction of the time and cost of using an MRI. It's of real importance in the treatment of infants and children with heart conditions. is a great made-in-Canada technology now being used in hospitals in Canada, the U.S., U.K. and Europe)
post Hugh (Yesterday I had the pleasure working with our Clinical Applications Manager Cristina Almeida during her upgrade of the system at the Seattle Children's Hospital to the new magnet-less sensors. It was a great opportunity to visit a customer site, observe and learn about their clinical environment and workflows, and discuss future development plans.) and now remember health Canada has approved us, FDA won’t be far behind. The visionary Dr. G. Adams and Alvira M. have done the long work that had to be done during all these years for Ventripoint to arrive V4.0 Bravo procurement in healthcare is complex . FDA V4.0 and Sales at any time now Insiders know!